Showing results (301-310 of 357) with videos related to

Sort By:
Pageof 36
Cancer Research|August 10, 2013
Downregulation of microRNA-515-5p by the estrogen receptor modulates sphingosine kinase 1 and breast cancer cell proliferationFilipa G Pinho, Adam E Frampton, Joao Nunes, et al.
Physics in Medicine and Biology|May 11, 2012
Imaging of cellular proliferation in liver metastasis by [18F]fluorothymidine positron emission tomography: effect of therapyKaiyumars Contractor, Amarnath Challapalli, Giampaolo Tomasi, et al.
EMBO Molecular Medicine|July 1, 2022
A novel platform for attenuating immune hyperactivity using EXO-CD24 in COVID-19 and beyondShiran Shapira, Marina Ben Shimon, Mori Hay-Levi, et al.
Oncotarget|May 4, 2018
Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burdenAdam E Frampton, Mireia Mato Prado, Elena López-Jiménez, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 7, 2023
Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled TrialJustin Stebbing, Yauheni Baranau, Valery Baryash, et al.
Oncogene|March 16, 2018
LMTK3 confers chemo-resistance in breast cancerJustin Stebbing, Kalpit Shah, Lei Cheng Lit, et al.
Science Signaling|June 19, 2014
The kinase LMTK3 promotes invasion in breast cancer through GRB2-mediated induction of integrin β₁Yichen Xu, Hua Zhang, Lei C Lit, et al.
Cancer Research|November 11, 2020
SCIRT lncRNA Restrains Tumorigenesis by Opposing Transcriptional Programs of Tumor-Initiating CellsSladjana Zagorac, Alex de Giorgio, Aleksandra Dabrowska, et al.
Endocrine-Related Cancer|June 30, 2016
MicroRNAs associated with small bowel neuroendocrine tumours and their metastasesHelen C Miller, Adam E Frampton, Anna Malczewska, et al.
Breast Cancer Research and Treatment|April 6, 2012
Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept studyMarta Pestrin, Silvia Bessi, Fabio Puglisi, et al.
Pageof 36